LPL Financial’s Meridian Bioscience Inc VIVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-6,763
Closed -$225K 4668
2022
Q4
$225K Buy
+6,763
New +$218K ﹤0.01% 3899
2022
Q3
Sell
-13,487
Closed -$410K 4554
2022
Q2
$410K Buy
13,487
+1,411
+12% +$38.2K ﹤0.01% 3376
2022
Q1
$314K Buy
+12,076
New +$287K ﹤0.01% 3541
2020
Q3
Sell
-18,880
Closed -$440K 3659
2020
Q2
$440K Sell
18,880
-1,090
-5% -$15.8K ﹤0.01% 2513
2020
Q1
$168K Buy
19,970
+330
+2% +$2.78K ﹤0.01% 2869
2019
Q4
$192K Sell
19,640
-9,425
-32% -$88.5K ﹤0.01% 3114
2019
Q3
$276K Sell
29,065
-1,300
-4% -$13.7K ﹤0.01% 2751
2019
Q2
$361K Buy
30,365
+725
+2% +$8.73K ﹤0.01% 2551
2019
Q1
$522K Buy
29,640
+7,381
+33% +$123K ﹤0.01% 2192
2018
Q4
$386K Buy
22,259
+934
+4% +$15.9K ﹤0.01% 2260
2018
Q3
$318K Sell
21,325
-489
-2% -$7.58K ﹤0.01% 2641
2018
Q2
$347K Buy
21,814
+312
+1% +$4.65K ﹤0.01% 2513
2018
Q1
$305K Buy
21,502
+4,196
+24% +$62.1K ﹤0.01% 2594
2017
Q4
$242K Buy
17,306
+2,478
+17% +$36.3K ﹤0.01% 2665
2017
Q3
$212K Buy
14,828
+6
+0% +$86 ﹤0.01% 2631
2017
Q2
$233K Buy
14,822
+2,342
+19% +$33.7K ﹤0.01% 2477
2017
Q1
$165K Sell
12,480
-2,577
-17% -$36K ﹤0.01% 2533
2016
Q4
$269K Buy
15,057
+982
+7% +$17.3K ﹤0.01% 2260
2016
Q3
$267K Buy
+14,075
New +$275K ﹤0.01% 2214

Other funds holding VIVO

LPL Financial's VIVO Position: Q1 2023 in Review

LPL Financial sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 6,763 shares — an estimated $225K sold.

LPL Financial first reported a position in VIVO in Q3 2016 and held it in 19 quarters. The position peaked at $522K in Q1 2019. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • LPL Financial reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • LPL Financial sold 6,763 Meridian Bioscience Inc shares in Q1 2023, an estimated $225K.
  • LPL Financial first reported a position in Meridian Bioscience Inc in Q3 2016 and held it in 19 quarters.
  • LPL Financial's Meridian Bioscience Inc position peaked at $522K in Q1 2019.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on LPL Financial's 13F filing for Q1 2023, filed 10 May 2023.